glp-1 что это Эволюция агонистов рецепторов глюкагоноподобного пептида-1 в терапии сахарного диабета 2 типа | Галстян Инъекции GLP-1 стали настоящим бестселлером

Ongoing research highlights the significant clinical potential of incretin-based therapies, especially in emerging areas such as central nervous system disorders, substance use, and post-transplant care

Men who have used tirzepatide report dramatic body composition changes that often exceed the averages reported in mixed-gender clinical trials

10.1016/j.cell.2013.12.016 Cell

Some patients find that taking supplements with a small meal helps reduce nausea, though this may be challenging given reduced appetite

Med Sci Monit 23:54105419 Sun HX, Lu N, Luo X, Zhao L, Liu JM (2015) Liraglutide, the glucagon-like peptide-1 receptor agonist, has anabolic bone effects in diabetic Goto-Kakizaki rats